Molecular pathogenesis of non-Hodgkin's lymphoma: The role of Bcl-6

被引:105
|
作者
Pasqualucci, L [1 ]
Bereschenko, O [1 ]
Niu, HF [1 ]
Klein, U [1 ]
Basso, K [1 ]
Guglielmino, R [1 ]
Cattoretti, G [1 ]
Dalla-Favera, R [1 ]
机构
[1] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA
关键词
non-Hodgkin's lymphoma; diffuse large B-cell lymphoma; somatic hypermutation; pathogenesis; Bcl-6; germinal center;
D O I
10.1080/10428190310001621588
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Non-Hodgkin's lymphomas (NHL) form a heterogeneous group of diseases, with diffuse large B-cell lymphoma (DLBCL) comprising the largest subgroup. The commonest chromosomal translocations found in DLBCL are those affecting band 3q27. In 35% of DLBCL cases, as well as in a small fraction of follicular lymphomas, the normal transcriptional regulation of Bcl-6 is disrupted by these chromosomal translocations. In addition, about three-quarters of cases of DLBCL display multiple somatic mutations in the 5' non-coding region of Bcl-6 , which occur independently of chromosomal translocations and appear to be due to the IgV-associated somatic hypermutation process. Bcl-6 is a 95-kD nuclear phosphoprotein belonging to the BTB/POZ (bric-a-brac, tramtrack, broad complex/Pox virus zinc finger) zinc finger family of transcription factors. It has been suggested that Bcl-6 is important in the repression of genes involved in the control of lymphocyte activation, differentiation, and apoptosis within the germinal center, and that its down-regulation is necessary for normal B-cells to exit the germinal center. Bcl-6 remains constitutively expressed in a substantial proportion of B-cell lymphomas. Recently, acetylation has been identified as a mode for down-regulating Bcl-6 activity by inhibition of the ability of Bcl-6 to recruit complexes containing histone deacetylases (HDAC). The pharmacologic inhibition of two recently identified deacetylation pathways, HDAC- and silent information regulator (SIR)-2-dependent deacetylation, results in the accumulation of inactive acetylated Bcl-6 and thus in cell cycle arrest and apoptosis in B-cell lymphoma cells. These results reveal a new method of regulating Bcl-6 , with the potential for therapeutic exploitation. These studies also indicate a novel mechanism by which acetylation promotes transcription, not only by modifying histones and activating transcriptional activators, but also by inhibiting transcriptional repressors.
引用
收藏
页码:S5 / S12
页数:8
相关论文
共 50 条
  • [1] BCL-6 in the pathogenesis of non-Hodgkin's lymphoma
    Ye, BH
    CANCER INVESTIGATION, 2000, 18 (04) : 356 - 365
  • [2] Molecular Pathogenesis of Non-Hodgkin's Lymphoma: the Role of Bcl-6 (vol 44, pg S5, 2003)
    Pasqualucci, L.
    Bereshchenko, Oxana
    Niu, H.
    LEUKEMIA & LYMPHOMA, 2013, 54 (05) : 1121 - 1121
  • [3] BCL-6 and other genomic alterations in non-Hodgkin's lymphoma (NHL)
    Butler, M
    Corbally, N
    Dervan, PA
    Carney, DN
    BRITISH JOURNAL OF CANCER, 1997, 75 (11) : 1641 - 1645
  • [4] Bcl-6 gene alterations in non-Hodgkin's lymphomas
    Chen, PM
    Lin, YC
    Chu, CJ
    Fan, FS
    Chiou, TJ
    Liu, JH
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S333 - S333
  • [5] Significance of Bcl-2 and Bcl-6 immunostaining in Non Hodgkin's lymphoma
    Mahmoud, Hanan Mohamed
    El-Sakhawy, Yasmin Nabil
    HEMATOLOGY REPORTS, 2011, 3 (03) : 80 - 85
  • [6] Pathogenesis of Non-Hodgkin's Lymphoma
    Nogai, Hendrik
    Doerken, Bernd
    Lenz, Georg
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (14) : 1803 - 1811
  • [7] BCL-6 AND THE MOLECULAR PATHOGENESIS OF B-CELL LYMPHOMA
    DALLAFAVERA, R
    YE, BH
    LOCOCO, F
    CHANG, CC
    CECHOVA, K
    ZHANG, J
    MIGLIAZZA, A
    MELLADO, W
    NIU, H
    CHAGANTI, S
    CHEN, W
    RAO, PH
    PARSA, NZ
    LOUIE, DC
    OFFIT, K
    CHAGANTI, RSK
    COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 1994, 59 : 117 - 123
  • [8] Alternative translocation breakpoint cluster region 5′ to BCL-6 in B-cell non-Hodgkin's lymphoma
    Butler, MP
    Iida, S
    Capello, D
    Rossi, D
    Rao, PH
    Nallasivam, P
    Louie, DC
    Chaganti, S
    Au, T
    Gascoyne, RD
    Gaidano, G
    Chaganti, RSK
    Dalla-Favera, R
    CANCER RESEARCH, 2002, 62 (14) : 4089 - 4094
  • [9] Molecular pathogenesis in non-Hodgkin lymphoma: Implications for therapy
    Vose, Julie M.
    TRANSFUSION AND APHERESIS SCIENCE, 2013, 49 (02) : 155 - 156
  • [10] Progressive translocation involving immunoglobulin (IG) heavy chain, BCL-2 and BCL-6 genes in non-Hodgkin's lymphoma (NHL).
    Koduru, P
    Zhou, XT
    Raymond, D
    Yenamandra, A
    Susin, M
    Broome, J
    BLOOD, 1999, 94 (10) : 176B - 177B